It all began with one doctor’s dream.
It won’t end until we find a cure.
A key member of the Johns Hopkins Division of Rheumatology since 1980, Dr. Ira T. Fine has dedicated his career to the care of patients with arthritis, autoimmune and inflammatory diseases. Anyone who has been treated by him appreciates his deep personal commitment to his patients and world-class expertise as an internist and practicing rheumatologist.
It has been Dr. Fine’s longtime wish to create a fund that will spark novel and innovative research to find cures for these diseases. In 2007, this vision became a reality when an anonymous donor started the Dr. Ira T. Fine Discovery Fund in his honor. The mission of the fund is to raise monies for research to end suffering caused by arthritis, autoimmune and inflammatory diseases and support new discoveries into their causes, mechanisms, diagnoses
and therapies.
Johns Hopkins: an unrivaled environment for conducting breakthrough rheumatology research
The Discovery Fund provides young investigators the opportunity to pursue their work within the Division of Rheumatology at Johns Hopkins. Dr. Fine, with his colleagues, awards funding, mentors and oversees the Discovery Fund’s research projects.
Dr. Fine recognizes that collaboration between outstanding physicians and top scientists is the key to achieving real progress in the fight against arthritis, autoimmune and inflammatory diseases. He also knows Johns Hopkins is the ideal place to make this happen. U.S. News & World Report has ranked Johns Hopkins Rheumatology the nation’s #1 rheumatology program for the last several years. A thriving clinical and academic center, the Division of Rheumatology concentrates on providing care to patients affected by a variety of common and uncommon rheumatic disorders. Many of the world’s foremost experts in the field have been trained or currently work at Johns Hopkins. Rich with expertise and infrastructure, this environment leverages every investment of the Discovery Fund.
